Track Ampio Pharmaceuticals, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Ampio Pharmaceuticals, Inc. AMPE Open Ampio Pharmaceuticals, Inc. in new tab

0.1526 USD
EPS
-10.66
P/B
0.04
ROE
-113.96
Beta
7.17
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Earnings dateMay 19, 2026
EPS-10.66
Book Value4.03
Price to Book0.04
Debt/Equity13.42
% Insiders1.529%
Estimates
Forward P/E-1.70
Forward EPS-0.09

DCF Valuation

Tweak assumptions to recompute fair value for Ampio Pharmaceuticals, Inc. (AMPE)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Ampio Pharmaceuticals, Inc. Logo Ampio Pharmaceuticals, Inc. Analysis (AMPE)

United States Health Care Official Website Stock

Is Ampio Pharmaceuticals, Inc. a good investment? Ampio Pharmaceuticals, Inc. (AMPE) is currently trading at 0.1526 USD.

Earnings Schedule: Ampio Pharmaceuticals, Inc. is expected to release its next earnings report on May 19, 2026. The market consensus estimate for Forward EPS is -0.09.

Investor FAQ

Does Ampio Pharmaceuticals, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Ampio Pharmaceuticals, Inc.?

Ampio Pharmaceuticals, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be May 19, 2026. The company currently has a trailing EPS of -10.66.

Company Profile

Ampio Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development of therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. The company develops OA-201, a small molecule formulation for the treatment of OAK pain. Ampio Pharmaceuticals, Inc. is based in Englewood, Colorado.

Exchange Ticker
ASE (United States) AMPE

Dividends

Historical Split Corporate Actions

Trades
Trade History
No trades yet
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion